Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ILF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EDEM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM183B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF113A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PVR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KBTBD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PQBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGDIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on